ZOLL Medical Corporation signed a definitive agreement to acquire Itamar Medical Ltd. (TASE:ITMR) for ILS 1.6 billion on September 13, 2021. ZOLL will acquire the shares of Itamar at ILS 3.31 per ordinary share, in cash. Under the transaction, Itamar’s WatchPAT® technology and Digital Health solution for sleep apnea will integrate with ZOLL Medical's commercial footprint. Once the acquisition is completed, it is expected that Itamar Medical’s principal operations will continue at its current location in Caesarea, Israel, including its R&D and Digital Health Technology centers, as well as the production center. Transaction is subject to approval by the shareholders of Itamar Medical, regulatory approvals and other customary closing conditions. Transaction is unanimously approved by the boards of directors of ZOLL Medical and Itamar. Itamar Medical’s shareholders meeting is scheduled on November 16, 2021 and Board of Itamar recommends the shareholders to vote in favor of the transaction. Itamar Medical Ltd announces that, at the Special and 2021 Annual General Meeting of Shareholders held on November 16, 2021, shareholders approved, by the requisite majority vote announced acquisition of the Company by ZOLL Medical Corporation. Transaction is expected to close by the end of 2021. The closing is expected in December 2021. As on December 15, 2021, transaction will close on December 16, 2021. The last trading day for ADSs and ordinary shares on the NASDAQ and TASE, respectively, will be December 15, 2021. Goldman Sachs & Co. LLC acted as financial advisor and Michal Berkner, Lester Fagen, and Michael McGrail of Cooley LLP and Gornitzky & Co. acted as legal advisors to ZOLL Medical Corporation. Piper Sandler & Co. acted as financial advisor and Hans Brigham, Max Schleusener, Nathan Ajiashvili, Michael Rosenberg, Elizabeth Richards, Betty Pang, Judith Hasko, Elena Romanova, Matthew Conway, Ian Conner, Patrick Englis, Damara Chambers and Heather Deixler of Latham & Watkins LLP, Joshua Kiernan of Latham & Watkins (London) LLP, Hector Armengod of Latham & Watkins LLP and Goldfarb Seligman & Co. acted as legal advisors to Itamar Medical Ltd. ZOLL Medical Corporation completed the acquisition of Itamar Medical Ltd. (TASE:ITMR) on December 16, 2021.